Analyst Ratings for Progenics Pharmaceuticals (pgnx)

pgnx Rating Summary

pgnx Price Target Summary

* Over Last 12-Mos
  |   Expand Research on pgnx
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $7.00 (+48.3%) * Over Last 12-Mos
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
9/23/2014 Jefferies New Coverage Hold
(N/A)
6.00
(N/A)
4.89 4.72 -3.48% Details
2/3/2014 Needham & Company
» Updated 9/30/2014
Upgrade Buy
(Hold)
8.00
(N/A)
4.78 4.72 -1.26% Details
Like PGNX Ratings? Also take a look at SLXP

PGNX Ratings News